You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Attention Score in Context
| Title |
Abstract CT224: mRNA-4157, a personalized cancer vaccine, in combination with pembrolizumab, demonstrates trend for improved recurrence free survival compared to pembrolizumab alone in adjuvant melanoma patients across tumor mutational burden subgroups
|
|---|---|
| Published in |
Cancer Research, May 2023
|
| DOI | 10.1158/1538-7445.am2023-ct224 |
| Authors |
Sullivan, Ryan J., Carlino, Matteo, Weber, Jeffrey S., Meniawy, Tarek, Taylor, Matthew H., Kim, Kevin, McKean, Meredith, Long, Georgiana V., Faries, Mark, Cowey, C. Lance, Pecora, Andrew, Gibney, Geoffrey T., Luke, Jason, Thomas, Sajeve, Sehgal, Vasudha, Feldman, Igor, Aanur, Praveen, Brown, Michelle, Meehan, Robert S., Robert-Tissot, Celine, Khattak, Adnan |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 November 2023.
All research outputs
#3,042,413
of 24,840,108 outputs
Outputs from Cancer Research
#2,554
of 18,985 outputs
Outputs of similar age
#54,229
of 371,275 outputs
Outputs of similar age from Cancer Research
#37
of 144 outputs
Altmetric has tracked 24,840,108 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 18,985 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,275 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 144 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.